These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 32194106

  • 1. Lipopolysaccharide derived alginate coated Hepatitis B antigen loaded chitosan nanoparticles for oral mucosal immunization.
    Saraf S, Jain S, Sahoo RN, Mallick S.
    Int J Biol Macromol; 2020 Jul 01; 154():466-476. PubMed ID: 32194106
    [Abstract] [Full Text] [Related]

  • 2. Immune response by nasal delivery of hepatitis B surface antigen and codelivery of a CpG ODN in alginate coated chitosan nanoparticles.
    Borges O, Cordeiro-da-Silva A, Tavares J, Santarém N, de Sousa A, Borchard G, Junginger HE.
    Eur J Pharm Biopharm; 2008 Jun 01; 69(2):405-16. PubMed ID: 18364251
    [Abstract] [Full Text] [Related]

  • 3. Hepatitis B surface antigen nanoparticles coated with chitosan and trimethyl chitosan: Impact of formulation on physicochemical and immunological characteristics.
    Tafaghodi M, Saluja V, Kersten GF, Kraan H, Slütter B, Amorij JP, Jiskoot W.
    Vaccine; 2012 Aug 03; 30(36):5341-8. PubMed ID: 22749834
    [Abstract] [Full Text] [Related]

  • 4. Development and characterization of surface modified PLGA nanoparticles for nasal vaccine delivery: effect of mucoadhesive coating on antigen uptake and immune adjuvant activity.
    Pawar D, Mangal S, Goswami R, Jaganathan KS.
    Eur J Pharm Biopharm; 2013 Nov 03; 85(3 Pt A):550-9. PubMed ID: 23831265
    [Abstract] [Full Text] [Related]

  • 5. Mucoadhesive glycol chitosan nanoparticles for intranasal delivery of hepatitis B vaccine: enhancement of mucosal and systemic immune response.
    Pawar D, Jaganathan KS.
    Drug Deliv; 2016 Nov 03; 23(1):185-94. PubMed ID: 24825494
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Development and characterization of LTA-appended chitosan nanoparticles for mucosal immunization against hepatitis B.
    Mishra N, Khatri K, Gupta M, Vyas SP.
    Artif Cells Nanomed Biotechnol; 2014 Aug 03; 42(4):245-55. PubMed ID: 23815286
    [Abstract] [Full Text] [Related]

  • 8. Oral hepatitis B vaccine: chitosan or glucan based delivery systems for efficient HBsAg immunization following subcutaneous priming.
    Soares E, Jesus S, Borges O.
    Int J Pharm; 2018 Jan 15; 535(1-2):261-271. PubMed ID: 29133207
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of the immune response following a short oral vaccination schedule with hepatitis B antigen encapsulated into alginate-coated chitosan nanoparticles.
    Borges O, Tavares J, de Sousa A, Borchard G, Junginger HE, Cordeiro-da-Silva A.
    Eur J Pharm Sci; 2007 Dec 15; 32(4-5):278-90. PubMed ID: 17884394
    [Abstract] [Full Text] [Related]

  • 10. Enteric trimethyl chitosan nanoparticles containing hepatitis B surface antigen for oral delivery.
    Farhadian A, Dounighi NM, Avadi M.
    Hum Vaccin Immunother; 2015 Dec 15; 11(12):2811-8. PubMed ID: 26158754
    [Abstract] [Full Text] [Related]

  • 11. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
    Bagre AP, Jain K, Jain NK.
    Int J Pharm; 2013 Nov 01; 456(1):31-40. PubMed ID: 23994363
    [Abstract] [Full Text] [Related]

  • 12. Poly(vinyl alcohol)-coated chitosan microparticles act as an effective oral vaccine delivery system for hepatitis B vaccine in rat model.
    Shrestha B, Rath JP.
    IET Nanobiotechnol; 2014 Dec 01; 8(4):201-7. PubMed ID: 25429498
    [Abstract] [Full Text] [Related]

  • 13. M-cell targeted delivery of recombinant hepatitis B surface antigen using cholera toxin B subunit conjugated bilosomes.
    Shukla A, Katare OP, Singh B, Vyas SP.
    Int J Pharm; 2010 Jan 29; 385(1-2):47-52. PubMed ID: 19835938
    [Abstract] [Full Text] [Related]

  • 14. Development of a novel adjuvanted nasal vaccine: C48/80 associated with chitosan nanoparticles as a path to enhance mucosal immunity.
    Bento D, Staats HF, Gonçalves T, Borges O.
    Eur J Pharm Biopharm; 2015 Jun 29; 93():149-64. PubMed ID: 25818119
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Development and physicochemical, toxicity and immunogenicity assessments of recombinant hepatitis B surface antigen (rHBsAg) entrapped in chitosan and mannosylated chitosan nanoparticles: as a novel vaccine delivery system and adjuvant.
    Mehrabi M, Dounighi NM, Rezayat Sorkhabadi SM, Doroud D, Amani A, Khoobi M, Ajdary S, Pilehvar-Soltanahmadi Y.
    Artif Cells Nanomed Biotechnol; 2018 Jun 29; 46(sup1):230-240. PubMed ID: 29260901
    [Abstract] [Full Text] [Related]

  • 17. Eudragit® L100-coated mannosylated chitosan nanoparticles for oral protein vaccine delivery.
    Xu B, Zhang W, Chen Y, Xu Y, Wang B, Zong L.
    Int J Biol Macromol; 2018 Jul 01; 113():534-542. PubMed ID: 29408613
    [Abstract] [Full Text] [Related]

  • 18. Enhancing Stability and Mucoadhesive Properties of Chitosan Nanoparticles by Surface Modification with Sodium Alginate and Polyethylene Glycol for Potential Oral Mucosa Vaccine Delivery.
    Amin MK, Boateng JS.
    Mar Drugs; 2022 Feb 22; 20(3):. PubMed ID: 35323455
    [Abstract] [Full Text] [Related]

  • 19. Single dose HBsAg CS-γ-PGA nanogels induce potent protective immune responses against HBV infection.
    Wang H, Han Q, Zhao H, Xu D, Zhang J.
    Eur J Pharm Biopharm; 2018 Mar 22; 124():82-88. PubMed ID: 29247691
    [Abstract] [Full Text] [Related]

  • 20. Preparation of alginate coated chitosan microparticles for vaccine delivery.
    Li X, Kong X, Shi S, Zheng X, Guo G, Wei Y, Qian Z.
    BMC Biotechnol; 2008 Nov 19; 8():89. PubMed ID: 19019229
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.